Picamilon is banned as a dietary supplement in the United States because the FDA determined it does not qualify as a dietary ingredient. On November 30, 2015, the agency issued warning letters to five supplement companies selling products containing picamilon, effectively removing it from the U.S. market. The substance remains a prescription drug in Russia, which is actually the core of the problem: it was developed as a pharmaceutical, not derived from food or botanical sources.
What Picamilon Actually Is
Picamilon is a synthetic compound that bonds niacin (vitamin B3) to GABA, a chemical the brain uses to calm neural activity. That bond is the key to how it works. GABA on its own cannot cross from the bloodstream into the brain. By attaching it to niacin, Soviet researchers in the 1960s and 70s created a molecule that slips through the blood-brain barrier, then splits apart once inside, releasing GABA directly where it can act on the nervous system. Its chemical name is nicotinoyl-GABA, and its molecular formula is C10H11N2NaO3.
In Russia, picamilon is prescribed for a range of neurological conditions. Clinical data from Russian studies report high efficacy rates (up to 89% for clinical outcomes), good tolerability in 98% of patients, and adverse events in fewer than 8.6% of cases. By pharmaceutical standards, that’s a relatively clean safety profile. But safety wasn’t the reason the FDA acted against it.
The FDA’s Legal Reasoning
Under U.S. law, a dietary supplement can only contain “dietary ingredients” as defined in the Federal Food, Drug, and Cosmetic Act. That definition covers vitamins, minerals, herbs, amino acids, and certain other substances that were already marketed in supplements before 1994 or that have gone through a New Dietary Ingredient (NDI) notification process with the FDA.
Picamilon fails this test on multiple fronts. It is not a vitamin, mineral, herb, or amino acid. It is a fully synthetic molecule created in a laboratory. While its two building blocks (niacin and GABA) are individually found in food and supplements, the bonded compound itself does not occur in nature and was never sold in U.S. supplements before the 1994 cutoff date. The FDA classified it under Category 3 of its dietary ingredient review: substances that simply are not dietary ingredients under the law.
No manufacturer successfully filed an NDI notification to get picamilon recognized as a new dietary ingredient. Without that approval, and without fitting any existing category, products containing it were considered adulterated under federal law.
The 2015 Crackdown
Before the FDA acted, picamilon had quietly spread through the supplement market, showing up in pre-workout formulas, nootropic stacks, and cognitive enhancement products. Some of these products contained doses that matched or even exceeded the amounts used in Russian prescriptions.
On November 30, 2015, the FDA issued warning letters to five companies:
- DBM Nutrition for DBM Endurance World Countess
- ICF International for Myokem Nitramine
- Top Secret Nutrition, LLC for Pump Igniter
- Applied Nutriceuticals, Inc. for HG4UP
- SDC Nutrition, Inc for NVIE Edge Pro
These letters required the companies to stop marketing products containing picamilon as dietary supplements. The action effectively pulled picamilon from legitimate U.S. retail channels.
Why “Not a Dietary Ingredient” Matters
The distinction sounds technical, but it carries real consequences. The FDA did not ban picamilon because it found it dangerous. It banned it because U.S. supplement law was never designed to accommodate synthetic pharmaceutical compounds developed in another country’s drug program. The legal framework draws a line between substances that come from food, plants, or the body’s own chemistry and substances engineered in a lab for pharmacological effect.
Picamilon sits in an awkward middle ground. Its components are benign and widely available. Niacin is in every multivitamin. GABA is sold as a standalone supplement (though its effectiveness when taken orally is debated, precisely because it struggles to reach the brain). But the synthetic bond that makes picamilon pharmacologically interesting is the same thing that makes it legally problematic in the U.S. It transforms two dietary ingredients into something that behaves like a drug.
Can You Still Buy Picamilon?
In the U.S., picamilon is no longer legally sold in dietary supplements. You may still find it through grey-market online vendors or overseas suppliers, but any product sold domestically as a supplement containing picamilon is technically in violation of federal law. The compound is not a controlled substance, so possessing it for personal use is not a criminal matter in the way that possessing a scheduled drug would be. The enforcement is directed at manufacturers and sellers, not individual buyers.
In Russia, picamilon remains an approved prescription medication available through pharmacies. Its regulatory status varies in other countries, and many nations simply have no specific ruling on it, meaning it falls into a regulatory grey area rather than being explicitly legal or illegal. If you’re considering purchasing it from an international source, the legal risk is low for personal quantities, but quality control and dosage accuracy from unregulated sellers is a genuine concern.
The Bigger Pattern
Picamilon is not the only compound the FDA has pulled from supplements using this reasoning. The agency maintains a list of substances it considers improperly marketed as dietary ingredients, and synthetic pharmaceutical compounds developed overseas are a recurring target. The logic is consistent: if a substance was designed as a drug and functions as a drug, selling it as a supplement bypasses the safety testing, dosage standardization, and medical oversight that drug approval requires. Whether that framework serves consumers well is a matter of ongoing debate, but it is the legal reality that keeps picamilon off U.S. shelves.